Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro
- 31 December 1993
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 26 (3) , 197-202
- https://doi.org/10.1016/0162-3109(93)90035-o
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Baboon-to-human liver transplantationThe Lancet, 1993
- Cladribine (2-chlorodeoxyadenosine)The Lancet, 1992
- CHRONIC VASCULAR REJECTION OF THE HEART AND THE KIDNEY—HAVE RATIONAL TREATMENT OPTIONS EMERGED?Transplantation, 1992
- Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.Journal of Clinical Investigation, 1990
- Normal B cell compartment in chronic lymphatic leukemiaHematological Oncology, 1990
- Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase CEuropean Journal of Immunology, 1989
- An optimal assay of human B cell proliferation in vitroJournal of Immunological Methods, 1987
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.Journal of Clinical Investigation, 1985
- Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytesBlood, 1983